ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.

Romain-David Seban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.